½ÃÀ庸°í¼­
»óǰÄÚµå
1279915

¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Cryoablation Devices Market Size study & Forecast, by Product by Application, by End Use and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀåÀº 2022³â ¾à 3¾ï 7,403¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â¿¡´Â 13.70% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

³Ãµ¿ ÀýÁ¦ ±â±â´Â ±ØÀú¿Â¿¡¼­ ¿øÄ¡ ¾Ê´Â Á¶Á÷À» ÆÄ±«ÇÏ¿© ´Ù¾çÇÑ Áõ»óÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ Àåºñ´Â ¾×ü Áú¼Ò ¶Ç´Â ¾Æ¸£°ï °¡½ºÀÇ Á¦¾î µÈ È帧À» Ç¥Àû Á¶Á÷¿¡ °ø±ÞÇÏ¿© Á¶Á÷À» µ¿°á½ÃŰ°í ±Ã±ØÀûÀ¸·Î Á¶Á÷À» Á×ÀÌ´Â ¹æ½ÄÀ¸·Î ÀÛµ¿ÇÕ´Ï´Ù. ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀåÀº ¾Ï À¯º´·ü Áõ°¡, ½É¹æ¼¼µ¿ À¯º´·ü Áõ°¡, ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

±¹Á¦¾Ï¿¬±¸¼Ò(IARC)ÀÇ ÃßÁ¤¿¡ µû¸£¸é ¼¼°è ¾Ï ¹ß»ýÀÌ 2021³â 190¸¸ ¸í¿¡¼­ 2040³â±îÁö 2,750¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¾Ï À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ CDC´Â 2030³â±îÁö 1,200¸¸ ¸íÀÇ ¹Ì±¹ÀÎÀÌ ½É¹æ¼¼µ¿À» ¾Î°Ô µÉ °ÍÀ¸·Î ÃßÁ¤Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½É¹æ¼¼µ¿Àº ¹Ì±¹¿¡¼­ ¸Å³â 45¸¸ °Ç¿¡ °¡±î¿î º´¿ø ÀÔ¿øÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ Áß ½É¹æ¼¼µ¿ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀåÀº ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ³Ãµ¿ ÀýÁ¦ ±â±âÀÇ ±â¼ú ¹ßÀü°ú ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÁöÃâ Áõ°¡´Â ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ³Ãµ¿ ÀýÁ¦ ±â±âÀÇ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÇ´Â ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ ¿ìÀ§, ¾Ï À¯º´·ü Áõ°¡, Ȱ¹ßÇÑ R&D Ȱµ¿À¸·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ ¹× ¾Ï À¯º´·ü Áõ°¡, Àåºñ °³¹ßÀ» À§ÇÑ °øµ¿ ¿¬±¸ Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ Áö¿ªÀû È®Àå, Á¤ºÎ ±â°ü ¹× ºñ¿µ¸® ´Üü ½ÃÀå ÁøÀÔ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¼ö³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí ÇâÈÄ ¼ö³â°£ÀÇ °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ½º³À¼ô
  • ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2020-2030³â
    • ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : Áö¿ªº°, 2020-2030³â
    • ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : Á¦Ç°º°, 2020-2030³â
    • ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : ¿ëµµº°, 2020-2030³â
    • ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëº°, 2020-2030³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç

Á¦2Àå ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
    • º» Á¶»çÀÇ ´ë»ó ¹üÀ§
  • Á¶»ç ´ë»ó³â
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå ¿ªÇÐ

  • ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ¾ÏÀÇ À¯º´·ü Áõ°¡
      • ½É¹æ¼¼µ¿ÀÇ À¯º´·ü »ó½Â
      • Àúħ½À¼ö¼úÀÇ ¼ö¿ä È®´ë
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
      • ³Ãµ¿ ÀýÁ¦ ±â±âÀÇ °íºñ¿ë
    • ½ÃÀå ±âȸ
      • ³Ãµ¿ ÀýÁ¦ ±â±âÀÇ ±â¼úÀû Áøº¸ÀÇ Áõ°¡
      • ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÁöÃâÀÇ Áõ°¡

Á¦4Àå ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È°ú °á·Ð

Á¦5Àå ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå, Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø : 2020-2030³â
  • ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Á¶Á÷ Á¢ÃËÇü ÇÁ·Îºê ¾Öºí·¹ÀÌÅÍ
    • Ç¥ÇÇ¡¤ÇÇÇÏ µ¿°á ÀýÁ¦ ½Ã½ºÅÛ
    • Á¶Á÷ ½ºÇÁ·¹ÀÌ ÇÁ·Îºê ¾Öºí·¹ÀÌÅÍ

Á¦6Àå ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : ¾ÖÇø®ÄÉÀ̼Ǻ°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ° ÃßÁ¤¡¤¿¹Ãø 2020-2030
  • ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • Æó¾Ï
    • °£¾Ï
    • À¯¹æ¾Ï
    • ½ÅÀå¾Ï
    • ±âŸ

Á¦7Àå ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå, ÃÖÁ¾ »ç¿ëº° ÃßÁ¤¡¤¿¹Ãø 2020-2030
  • ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • º´¿ø
    • ¿Ü·¡ ȯÀÚ ½Ã¼³
    • ¿¬±¸¡¤Á¦Á¶ ºÐ¾ß

Á¦8Àå ¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå : Áö¿ªº° ºÐ¼®

  • »óÀ§ÀÇ ÁÖ¿ä ±¹°¡
  • »óÀ§ ½ÅÈï ±¹°¡
  • ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå, Áö¿ªº° ½ÃÀå ½º³À¼ô
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ¾ÖÇø®ÄÉÀ̼Ǻ° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾ »ç¿ë ³»¿ª ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå ½º³À¼ô
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå ½º³À¼ô
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå ½º³À¼ô
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
    • ±â¾÷ 1
    • ±â¾÷ 2
    • ±â¾÷ 3
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Boston Scientific Corporation
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫 Á¤º¸(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¸¸)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Micro Port Scientific Corporation.
    • Medtronic
    • COOPERSURGICAL, INC.
    • ATRICURE, INC.
    • BVM Medical Limited
    • CPSI Biotech
    • Ice Cure Medical
    • METRUM CRYOFLEX Sp. z o.o.
    • Sanarus Technologies

Á¦10Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • ¹ë¸®µ¥À̼Ç
    • ÃâÆÇ
  • Á¶»çÀÇ Æ¯Â¡
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
KSA 23.06.12

Global Cryoablation Devices Market is valued at approximately USD 374.03 million in 2022 and is anticipated to grow with a healthy growth rate of more than 13.70% over the forecast period 2023-2030. Cryoablation devices are medical instruments used to treat a variety of conditions by using extremely cold temperatures to destroy unwanted tissue. The devices work by delivering a controlled stream of liquid nitrogen or argon gas to the target tissue, which causes the tissue to freeze and ultimately die. The Cryoablation Devices Market is expanding because of factors such as the increasing prevalence of cancer, the rising prevalence of atrial fibrillation and the growing demand for minimally invasive surgeries.

The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Furthermore, by 2030, the CDC estimated that 12 million Americans would have atrial fibrillation.. In addition, atrial fibrillation was the primary diagnosis in almost 450,000 hospital admissions in the United States each year. During the projection period, it is anticipated that the market for cryoablation devices would have increased demand due to the rising prevalence of atrial fibrillation. In Addition, the rising number of technological advancements in cryoablation devices and rising spending on research and development activities are creating a lucrative opportunity for the market. However, the high cost of Cryoablation Devices may hamper the market growth.

The key regions considered for the Global Cryoablation Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to dominance of key market players, the rising prevalence of cancer and rising research and development activities. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and cancer prevalence, an increase in the number of collaborations for device development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Boston Scientific Corporation
  • Micro Port Scientific Corporation.
  • Medtronic
  • COOPERSURGICAL, INC.
  • ATRICURE, INC.
  • BVM Medical Limited
  • CPSI Biotech
  • Ice Cure Medical
  • METRUM CRYOFLEX Sp. z o.o.
  • Sanarus Technologies

Recent Developments in the Market:

  • In August 2022, Medtronic plc acquired Affera, Inc., a medical technology manufacturer. This acquisition results in the expansion of Medtronic in its ablation portfolio by comprising the cardiac navigation as well as the mapping platform.
  • In April 2021, IceCure Medical Granted FDA Breakthrough Device Designation for ProSense® Cryoablation System. The FDA will offer a priority assessment and comments throughout development and commercialization under the programme. The FDA-accelerated collaborative discussion is something IceCure is looking forward to in order to hasten the commercialization of ProSense® for the treatment of benign and malignant tumours.

Global Cryoablation Devices Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Product, Application, End Use, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Tissue Contact Probe Ablators
  • Epidermal and Subcutaneous Cryoablation Systems
  • Tissue Spray Probe Ablators

By Application:

  • Lung Cancer
  • Liver Cancer
  • Breast Cancer
  • Kidney Cancer
  • Others

By End Use:

  • Hospital
  • Outpatient Facilities
  • Research & Manufacturing

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Cryoablation Devices Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Cryoablation Devices Market, by Product, 2020-2030 (USD Million)
    • 1.2.3. Cryoablation Devices Market, by Application, 2020-2030 (USD Million)
    • 1.2.4. Cryoablation Devices Market, by End Use, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cryoablation Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cryoablation Devices Market Dynamics

  • 3.1. Cryoablation Devices Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of cancer
      • 3.1.1.2. Rising prevalence of atrial fibrillation
      • 3.1.1.3. Growing demand for minimally invasive surgeries
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Cryoablation Devices
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising number of technological advancements in cryoablation devices
      • 3.1.3.2. Rising spending on research and development activities

Chapter 4. Global Cryoablation Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Cryoablation Devices Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Cryoablation Devices Market by Product, Performance - Potential Analysis
  • 5.3. Global Cryoablation Devices Market Estimates & Forecasts by Product 2020-2030 (USD Million)
  • 5.4. Cryoablation Devices Market, Sub Segment Analysis
    • 5.4.1. Tissue Contact Probe Ablators
    • 5.4.2. Epidermal and Subcutaneous Cryoablation Systems
    • 5.4.3. Tissue Spray Probe Ablators

Chapter 6. Global Cryoablation Devices Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Cryoablation Devices Market by Application, Performance - Potential Analysis
  • 6.3. Global Cryoablation Devices Market Estimates & Forecasts by Application 2020-2030 (USD Million)
  • 6.4. Cryoablation Devices Market, Sub Segment Analysis
    • 6.4.1. Lung Cancer
    • 6.4.2. Liver Cancer
    • 6.4.3. Breast Cancer
    • 6.4.4. Kidney Cancer
    • 6.4.5. Others

Chapter 7. Global Cryoablation Devices Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Cryoablation Devices Market by End Use, Performance - Potential Analysis
  • 7.3. Global Cryoablation Devices Market Estimates & Forecasts by End Use 2020-2030 (USD Million)
  • 7.4. Cryoablation Devices Market, Sub Segment Analysis
    • 7.4.1. Hospital
    • 7.4.2. Outpatient Facilities
    • 7.4.3. Research & Manufacturing

Chapter 8. Global Cryoablation Devices Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Cryoablation Devices Market, Regional Market Snapshot
  • 8.4. North America Cryoablation Devices Market
    • 8.4.1. U.S. Cryoablation Devices Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Cryoablation Devices Market
  • 8.5. Europe Cryoablation Devices Market Snapshot
    • 8.5.1. U.K. Cryoablation Devices Market
    • 8.5.2. Germany Cryoablation Devices Market
    • 8.5.3. France Cryoablation Devices Market
    • 8.5.4. Spain Cryoablation Devices Market
    • 8.5.5. Italy Cryoablation Devices Market
    • 8.5.6. Rest of Europe Cryoablation Devices Market
  • 8.6. Asia-Pacific Cryoablation Devices Market Snapshot
    • 8.6.1. China Cryoablation Devices Market
    • 8.6.2. India Cryoablation Devices Market
    • 8.6.3. Japan Cryoablation Devices Market
    • 8.6.4. Australia Cryoablation Devices Market
    • 8.6.5. South Korea Cryoablation Devices Market
    • 8.6.6. Rest of Asia Pacific Cryoablation Devices Market
  • 8.7. Latin America Cryoablation Devices Market Snapshot
    • 8.7.1. Brazil Cryoablation Devices Market
    • 8.7.2. Mexico Cryoablation Devices Market
  • 8.8. Middle East & Africa Cryoablation Devices Market
    • 8.8.1. Saudi Arabia Cryoablation Devices Market
    • 8.8.2. South Africa Cryoablation Devices Market
    • 8.8.3. Rest of Middle East & Africa Cryoablation Devices Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Boston Scientific Corporation
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Micro Port Scientific Corporation.
    • 9.3.3. Medtronic
    • 9.3.4. COOPERSURGICAL, INC.
    • 9.3.5. ATRICURE, INC.
    • 9.3.6. BVM Medical Limited
    • 9.3.7. CPSI Biotech
    • 9.3.8. Ice Cure Medical
    • 9.3.9. METRUM CRYOFLEX Sp. z o.o.
    • 9.3.10. Sanarus Technologies

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦